Michael M I Abecassis

15PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)AllergyGene and molecular therapyTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 12, 2021
Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.

Josh Levitsky, Manoj Kandpal, Kexin Guo

|Sep 18, 2020
Letter to the AJT Editor re: Puttarajappa et al (doi:10.1111/ajt.16150).

Abhijit S Grewal, John J Friedewald, Michael M Abecassis

|Jul 14, 2020
Acute murine cytomegalovirus disrupts established transplantation tolerance and causes recipient allo-sensitization.

Shuangjin Yu, Anil Dangi, Melanie Burnette

|Feb 25, 2020
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.

Roslyn B Mannon, Randall E Morris, Michael Abecassis

|Apr 05, 2019
A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Zheng Zhang, Longhui Qiu, Shixian Yan

|Feb 28, 2019
Clinical implications for the use of a biomarker for subclinical rejection - Conflating arguments cause a disconnection between the premise and the conclusion.

John Friedewald, Michael Abecassis

Pageof 3